Process measure of FAST tuberculosis infection control demonstrates delay in likely effective treatment.
Int J Tuberc Lung Dis
http://www.ncbi.nlm.nih.gov/pubmed/30621813
Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".
Antimicrob Agents Chemother
http://www.ncbi.nlm.nih.gov/pubmed/28839086
Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis.
Antimicrob Agents Chemother
http://www.ncbi.nlm.nih.gov/pubmed/28559269
Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
Int J Tuberc Lung Dis
http://www.ncbi.nlm.nih.gov/pubmed/28157458
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.
Eur Respir J
http://www.ncbi.nlm.nih.gov/pubmed/27587552
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.
BMC Infect Dis
http://www.ncbi.nlm.nih.gov/pubmed/27567500